Sumary of Black, Hispanic patients with RA exhibit higher disease activity, worse functional status:
- November 17, 2021 3 min read Source/Disclosures Published by: Source: O’Brien J.
- Please see the study for all other authors’ relevant financial disclosures.
- Source: Adobe Stock “This is an area that has been under studied in rheumatoid arthritis,” Jacqueline O’Brien, ScD, a clinical epidemiologist at the disease registry provider CorEvitas, formerly known as Corrona, told attendees at a virtual press conference.
- “We have a rich data source following RA patients over many years, systematically collecting information about patient characteristics, their clinical progress and the medications people take.
- ” To determine whether clinical outcomes differ by race and ethnicity in RA within their own registry population, O’Brien and colleagues studied data from the more than 56,000 patients across 42 states contained in the CorEvitas’ RA Registry.
- The researchers included patients with at least one visit during two time periods — 2013 to 2015 and 2018 to 2020 — selecting the first visit from the first period and the last visit in the second period for analysis.
- Race and ethnicity were self-reported at enrollment, while Clinical Disease Activity Index (CDAI) scores were obtained at each visit.
- Secondary outcomes included the proportion of patients in low disease activity — defined as a CDAI score of 10 or less — or remission — a CDAI score of 2.8 or less — and HAQ-disability index at each visit.